Finance

Lists
Why is 1752 up 5.56%?
Dive Deeper
1752:TPE
Nang Kuang Pharmaceutical Co Ltd
NT$33.25
+5.56%
(+1.75) 1D
Oct 8, 1:30:02 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1752...
Open
NT$31.60
High
NT$33.35
Low
NT$31.60
Mkt. cap
3.36B
Avg. vol.
41.81K
Volume
357.65K
Dividend
4.81%
Quarterly dividend
NT$0.40
Ex-dividend date
Jul 2, 2026
P/E ratio
16.38
52-wk high
NT$39.55
52-wk low
NT$31.10
EPS
NT$2.03
No. of employees
552
Open
NT$31.60
High
NT$33.35
Low
NT$31.60
Mkt. cap
3.36B
Avg. vol.
41.81K
Volume
357.65K
Dividend
4.81%
Quarterly dividend
NT$0.40
Ex-dividend date
Jul 2, 2026
P/E ratio
16.38
52-wk high
NT$39.55
52-wk low
NT$31.10
EPS
NT$2.03
No. of employees
552
News stories
From web sources and news partners
About Nang Kuang Pharmaceutical Co Ltd
CEO-
Employees552
Founded1963
Headquarters-
SectorPharmaceutical industry
Websitenangkuang.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
523.84M
517.20M
529.63M
538.59M
Cost of goods sold
356.02M
336.54M
342.12M
340.37M
Cost of revenue
356.02M
336.54M
342.12M
340.37M
Research and development expenses
41.35M
38.21M
38.12M
44.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75.20M
79.31M
78.63M
77.50M
Operating expense
116.55M
117.52M
116.75M
122.14M
Total operating expenses
472.56M
454.06M
458.87M
462.52M
Operating income
51.27M
63.13M
70.76M
76.07M
Other non operating income
1.56M
5.33M
2.12M
2.23M
EBT including unusual items
57.04M
76.32M
45.21M
64.37M
EBT excluding unusual items
56.65M
71.02M
72.46M
75.64M
Income tax expense
10.40M
2.97M
13.19M
12.63M
Effective tax rate
18.23%
3.90%
29.17%
19.62%
Other operating expenses
-
-
-
-
Net income
46.64M
73.82M
32.56M
52.37M
Net profit margin
8.90%
14.27%
6.15%
9.72%
Earnings per share
-
-
-
-
Interest and investment income
519.00K
1.11M
576.00K
1.02M
Interest expense
-2.23M
-2.39M
-2.26M
-2.04M
Net interest expenses
-1.71M
-1.28M
-1.68M
-1.02M
Depreciation and amortization charges
-
-
-
-
EBITDA
96.96M
107.78M
115.20M
121.10M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps